Dextera Surgical Inc (NASDAQ:DXTR) shares traded 2.08% up during most recent session to reach at the closing price of $0.25. The stock exchanged hands 2.14 Million shares versus average trading capacity of 6.28 Million shares, yielding a market cap of $2.23 Million. Wall Street analysts covering the stock are projecting that the stock will reach $0.7 within the next 52-weeks. The mean target projections are based on 2 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Dextera Surgical Inc (NASDAQ:DXTR) high price target of $0.7 and with a conservative view have low price target of $0.7.

Wedbush “Maintained” Dextera Surgical Inc (NASDAQ:DXTR) in a research note issued to investors on 7/12/17 to Outperform with price target of $0.7.

On the other hand the company has Relative Strength Index (RSI 14) of 47.04 along with Average True Range (ATR 14) of 0.04, Consequently Dextera Surgical Inc (NASDAQ:DXTR)’s weekly and monthly volatility is 5.64%, 14.04% respectively. The company’s beta value is at -0.97.

In terms of Buy, Sell or Hold recommendations, Dextera Surgical Inc (NASDAQ:DXTR) has analysts’ mean recommendation of 2. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Dextera Surgical Inc (NASDAQ:DXTR)’s minimum EPS for the current quarter is at $-0.11 and can go high up to $-0.1. The consensus mean EPS for the current quarter is at $-0.11 derived from a total of 2 estimates from the analysts who have weighed in on projected earnings. However the company reported $-0.48 earnings per share for the same quarter during last year.

Previously Dextera Surgical Inc (NASDAQ:DXTR) reported $-0.5 earnings per share (EPS) for the quarter, missing the consensus estimate of $-0.49 by $-0.01. The company posted an earnings surprise of -2%.

Dextera Surgical Inc (NASDAQ:DXTR)’s revenue estimates for the current quarter are $1.1 Million according to 2 number of analysts, for the current quarter the company has high revenue estimates of $1.18 Million in contradiction of low revenue estimates of $1.03 Million. For the current year the company’s revenue estimates are $3.47 Million compared to low analyst estimates of $3.4 Million and high estimates of $3.55 Million according to 2 number of analysts.

Currently Dextera Surgical Inc (NASDAQ:DXTR)’s shares owned by insiders are 0.3%, whereas shares owned by institutional owners are 33.9%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 0%.

Dextera Surgical Inc (NASDAQ:DXTR) 52-week high price stands at $2.94 and low price stands at $0.17, its price distance from 52-week high is -91.49% while its distance from 52-week low price is 47.12%. The stock hit its 52-week high on 08/01/16, and 52-week low on 05/30/17.

Dextera Surgical Inc (NASDAQ:DXTR)’s trailing twelve month revenues are $3.1 Million, whereas its price to sales ratio for the same period is 0.72. Its book value per share for the most recent quarter is $-2.36 while its price to book ratio for the same period is 0, as for as the company’s cash per share for the most recent quarter is $0.28, however its price to cash per share ratio for the same period is 0.89. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.